Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'gsk 3 inhibitor 1'

Search results for: 'gsk 3 inhibitor 1'

Items 31-40 of 67

Page
per page
  1. Ro 3306
    A8885 Ro 3306
     4 Citation
    Target: Cyclin-Dependent Kinases
    Summary: An ATP-competitive, potent CDK1 inhibitor
      insoluble in EtOH; insoluble in H2O; ≥4.39 mg/mL
  2. VRT752271
    B1106 VRT752271
    Target: ERK
    Summary: ERK1/ERK2 inhibitor
      ≥43.3 mg/mL
  3. N6022
    B1111 N6022
    Target: S-nitrosoglutathione reductase
    Summary: GSNOR inhibitor
      insoluble in EtOH; insoluble in H2O; ≥20.7 mg/mL
  4. MG-262
    A8179 MG-262
     1 Citation
    Target: Proteasome
    Summary: Proteasome inhibitor
      ≥24.57 mg/mL
  5. Tubacin
    A4501 Tubacin
     3 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC6 inhibitor,potent,selective,reversible,cell-permeable
      insoluble in EtOH; insoluble in H2O; ≥7.19 mg/mL
  6. GSK1070916
    A4127 GSK1070916
    Target: Aurora Kinases
    Summary: Aurora B/C inhibitor
      ≥25.4 mg/mL
  7. SID 26681509
    A4424 SID 26681509
    Target: Cathepsins
    Summary: Human cathepsin L inhibitor,potent and reversible
      <26.98 mg/mL
  8. Dabrafenib (GSK2118436)
    B1407 Dabrafenib (GSK2118436)
     3 Citation
    Target: Raf
    Summary: Inhibitor of BRAF(V600) mutants
      ≥26 mg/mL
  9. Otamixaban
    A3690 Otamixaban
    Target: Factor Xa
    Summary: Direct factor Xa inhibitors,potent and selective
      ≥22.35 mg/mL
  10. LDN 57444
    A4003 LDN 57444
    Target: UCH
    Summary: UCH-L1 inhibitor,reversible competitve
      insoluble in EtOH; insoluble in H2O; ≥16.7 mg/mL

Items 31-40 of 67

Page
per page
Shop By
Now Shopping by
  1. Reversibility Reversible Remove This Item
Clear All
Shopping Options
Category
  1. Biotinylation reagents and kits 1 item
  2. Signaling Pathways 66item
  3. Protein & Immunology 1 item
Specificity
  1. Selective 54item
  2. Non-Selective 1 item
Target
  1. Caspases 1 item
  2. Cyclin-Dependent Kinases 2item
  3. Proteasome 3item
  4. Cathepsins 4item
  5. Histone Deacetylases (HDACs) 2item
  6. Akt 1 item
  7. PI3K 2item
  8. CXCR 1 item
  9. Raf 1 item
  10. Aurora Kinases 2item
  11. mTOR 1 item
  12. MMP 1 item
  13. Myosin II ATPases 1 item
  14. Factor Xa 1 item
  15. PLK 1 item
  16. Chk 1 item
  17. JNK 1 item
  18. MEK 1 item
  19. Deubiquitinating enzymes (DUBs) 1 item
  20. Src 1 item
  21. NMDA Receptors 1 item
  22. Microtubules/Tubulins 2item
  23. EGFR 2item
  24. sulfhydryls (-SH) 1 item
  25. FAK 3item
  26. JAK 2item
  27. Syk 1 item
  28. AMPK 1 item
  29. S-nitrosoglutathione reductase 1 item
  30. CFTR 1 item
  31. thrombin 1 item
  32. ErbB 2item
  33. Actin 1 item
  34. ERK 1 item
  35. PKC 1 item
  36. Calpains 1 item
  37. M1 Receptors 1 item
  38. SMYD2 1 item
  39. RAD51 1 item
  40. Trypsins 1 item
  41. Pyk2 3item
  42. Insulin and Insulin-like Receptors 1 item
  43. ALK 1 item
  44. GTPases 1 item
  45. CETP 1 item
  46. PKA 1 item
  47. Myosin light chain kinases (MLCKs) 1 item
  48. MK2 1 item
  49. ATM/ATR 1 item
  50. AChE 1 item
  51. ZAP-70 1 item
  52. Catechol O-Methyltransferase (COMT) 1 item
  53. DPP-4 1 item
  54. Dipeptidyl-peptidase II 1 item
  55. P97 ATPase 1 item
  56. Aromatases 1 item
  57. UCH 1 item
  58. MST 1 item
  59. ATM 1 item
Reported Experiments
  1. Animal Experiments 55item
  2. Cell Experiments 34item
Related Disease
  1. Acute Myelogenous Leukemia 1 item
  2. Acute Myeloid Leukemia 1 item
  3. Breast Cancer 9item
  4. Cancer 28item
  5. Colon Cancer 3item
  6. Colorectal Cancer 2item
  7. Diabetes 1 item
  8. Glioblastoma 1 item
  9. Glioma 1 item
  10. Hepatocellular Carcinoma 2item
  11. Hypercholesterolemia 1 item
  12. Inflammatory Diseases 2item
  13. Leukemia 2item
  14. Lung Cancer 2item
  15. Lymphoma 1 item
  16. Mantle Cell Lymphoma 1 item
  17. Multiple Myeloma 1 item
  18. Pancreatic Cancer 4item
  19. Psoriasis 1 item
  20. Pyridyldithiol-activated 1 item
  21. Renal Cancer 1 item
  22. Rheumatoid Arthritis 1 item